Capricor stockholders approve 2025 Equity Incentive Plan (3.5M shares plus 5% annual increase)

CAPRICOR THERAPEUTICS, INC.

Stockholders approved 2025 Equity Incentive Plan (3.5M shares reserved) with ~54% of votes cast in favor (9.7M FOR, 8.2M AGAINST).
Plan includes annual evergreen increase of 5% of outstanding shares from 2026 through 2035.
Rose, Snyder & Jacobs LLP ratified as independent auditor for FY2025.
Say-on-pay advisory vote passed with ~92% in favor (16.4M FOR, 1.5M AGAINST).
30.55M shares present (66.9% of outstanding) at annual meeting on May 22, 2025.

item 5.02item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.